Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

Weight-loss supplements promise quick results but often lack scientific backing. Popular ingredients like caffeine, green tea ...

The popularity of dietary supplements has risen significantly in the recent years, primarily owing to the increasing preference of people to lead a healthy lifestyle. Considering the myriad ...

Eli Lilly & Co. (LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026. CEO Dave Ricks told Bloomberg News on Monday that data on the drug, orforglipron, is ...

Pills would be more convenient for patients and also easier to manufacture at large scale than other top weight-loss drugs, which require , CEO Dave Ricks said.

Eli Lilly expects its experimental weight loss pill, orforglipron, to be approved as soon as early next year, CEO David Ricks told Bloomberg. Eli Lilly and Novo Nordisk, which dominate the market ...

A little over two years ago, a whisper of a new drug was abundant. Ozempic was quickly deemed a “miracle” medication, though few could predict how quickly and vastly it would revolutionise the ...

Eli Lilly (LLY) expects that its experimental weight loss pill will get approved as soon as early next year, CEO David Ricks said in an interview with Bloomberg TV at the JPMorgan Healthcare ...